S&P Futures
3,986.75 +3.75 (+0.09%) Dow Futures
32,473.00 +17.00 (+0.05%) Nasdaq Futures
12,695.00 +6.50 (+0.05%) Russell 2000 Futures
1,765.50 +4.80 (+0.27%) Crude Oil
67.15 -0.49 (-0.72%) Gold
1,986.10 +3.30 (+0.17%)
ThermoGenesis Holdings, Inc. (THMO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 5.0500 |
| Open | 4.9600 |
| Bid | 0.0000 x 1100 |
| Ask | 0.0000 x 1800 |
| Day's Range | 4.1500 - 4.9600 |
| 52 Week Range | 2.1100 - 40.5000 |
| Volume | |
| Avg. Volume | 1,205,615 |
| Market Cap | 5.496M |
| Beta (5Y Monthly) | 2.61 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -67.8500 |
| Earnings Date | Mar 27, 2023 - Mar 31, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 45.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for THMO
Related Research
- ThermoGenesis Holdings, Inc.VCEL: Raising target price to $32.00VERICEL CORP has an Investment Rating of HOLD; a target price of $32.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.RatingFair ValueEconomic Moat6 days agoArgus Research
- PR Newswire
THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced the closing of its previously announced purchase and sale of 1,071,429 shares of its common stock (or common stock equivalents) and warrants to purchase up to 1,071,429 shares of its common stock at a purchase price of $2.80 per share of common stock (or common stock equivalent) and associated warrant in a private placement priced at-the
- MarketWatch
First Republic Bank’s stock plunge continues despite $30 billion bank boost, FedEx’s stock jumps after blowout earnings report
FedEx's stock soared and XPeng shares reversed higher, while shares of Credit Suisse and XPeng were among decliners on Friday.
- PR Newswire
THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has entered into definitive agreements for the purchase and sale of 1,071,429 shares of its common stock (or common stock equivalents) and warrants to purchase 1,071,429 shares of its common stock at a purchase price of $2.80 per share of common stock (or common stock equivalent) and associated warrant in a private placement pric
